A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

PHASE2CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

August 4, 2021

Primary Completion Date

October 19, 2022

Study Completion Date

October 19, 2022

Conditions
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Interventions
DRUG

Efinopegdutide 20 mg/mL

Subcutaneous injection in a dose-escalation administration of 2.4 mg, 5.0 mg, and 10.0 mg

DRUG

Semaglutide 1.34 mg/mL

Subcutaneous injection in a dose-escalation administration of 0.25 mg, 0.5 mg, and 1.0 mg

Trial Locations (69)

333

Chang Gung Medical Foundation-Linkou Branch-Division of hepatology, department of gastroenterology (, Taoyuan District

704

NATIONAL CHENG-KUNG UNI. HOSP.-Liver Research team of National Cheng Kung University Hospital ( Site, Tainan City

1023

Auckland City Hospital-Liver Research Unit ( Site 1003), Auckland

2025

Middlemore Clinical Trials ( Site 1000), Auckland

2145

Westmead Hospital-Gastroenterology & Hepatology ( Site 0204), Westmead

5042

Flinders Medical Centre-Hepatology and Liver Transplant Medicine ( Site 0201), Bedford Park

8011

Christchurch Hospital-Gastroenterology Research ( Site 1002), Christchurch

10002

National Taiwan University Hospital ( Site 1501), Taipei

14050

Medica Sur-Clinica de Enfermedades Digestivas y Obesidad ( Site 0908), Mexico City

14584

Soon Chun Hyang University Bucheon Hospital ( Site 1304), Bucheon-si

15706

CHUS - Hospital Clinico Universitario ( Site 1403), Santiago de Compostela

20089

Humanitas-Medicina interna ed Epatologia ( Site 0800), Rozzano

20122

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico ( Site 0805), Milan

21000

Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital F-ENDOCRINOLOGY-DIABETOLOGY ( Site 0401), Dijon

22332

Inha University Hospital-Gastroenterolgy/Hepatology ( Site 1303), Incheon

28222

HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Gastroenterologia y Hepatologia ( Site 1402), Madrid

28557

Lucas Research, Inc ( Site 1930), Morehead City

29010

Hospital Universitario Virgen de la Victoria-UGC Endocrinologia y nutricion ( Site 1405), Málaga

33016

Sweet Hope Research Specialty, Inc ( Site 1902), Hialeah

Floridian Clinical Research, LLC ( Site 1950), Miami Lakes

34093

Bezmialem Vakf Üniversitesi-Gastroenterology ( Site 1606), Istanbul

Istanbul University Capa Campus-Gastroenterology ( Site 1604), Istanbul

34761

Sensible Healthcare, LLC ( Site 1903), Ocoee

35330

Dokuz Eylül Üniversitesi-Endocrinology and Met. ( Site 1610), Balçova

36011

Poltova Oblast Clinical Hospital IM.M.V.Sklifosovskoho ( Site 1710), Poltava

37134

Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Roma-Medicine ( Site 0804), Verona

41013

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Unidad de Ensayos Clínicos de Aparato Digestivo ( Site 1404), Seville

41125

Azienda Ospedaliero Universitaria ( Site 0803), Modena

49100

Rabin Medical Center ( Site 0701), Petah Tikva

61039

L.T. Mala National Institute of Therapy of NAMS of Ukraine-Department of Aging Studies and Prevent, Kharkiv

64710

Avix Investigación Clinica, S.C. ( Site 0907), Monterrey

69035

"Communal Non-profit Enterprise City Hospital #6 of Zaporizhzhia City Council-Therapy department (", Zaporizhia

69310

centre hospitalier lyon sud-Endocrinologie, Diabète et Nutrition ( Site 0402), Pierre-Bénite

76012

Texas Clinical Research Institute ( Site 1910), Arlington

77030

Baylor College of Medicine-Advanced Liver Therapies ( Site 1960), Houston

78215

American Research Corporation at Texas Liver Institute ( Site 1920), San Antonio

78229

Clinical Trials of Texas, Inc. ( Site 1906), San Antonio

91763

Catalina Research Institute, LLC ( Site 1939), Montclair

97130

Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan (, Mérida

125008

Center targetnoy therapy ( Site 1203), Moscow

140091

New Technologies of Medicine Clinic ( Site 1204), Dzerzhinskiy

194358

Saint Petersburg City Polyclinic 117-endocrinology department ( Site 1201), Saint Petersburg

199226

Astarta Clinic ( Site 1202), Saint Petersburg

310039

Ukrainian Research Institute of Therapy ( Site 1704), Kharkiv

3109601

Rambam Health Care Campus-Liver disease unit ( Site 0704), Haifa

3436212

Carmel Hospital-Liver Unit ( Site 0705), Haifa

5262100

Sheba Medical Center-The Liver Diseases Center ( Site 0700), Ramat Gan

6423906

Sourasky Medical Center-Gastroenterology and Liver Disease ( Site 0702), Tel Aviv

9778419

Shaare Zedek Medical Center-Liver Unit ( Site 0703), Jerusalem

C1119ACN

CIPREC-Laboratorio ( Site 0104), Ciudad Autonoma de Buenos Aires

B7600FZO

Instituto de Investigaciones Clínicas Mar del Plata ( Site 0101), Mar del Plata

C1425AGC

Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada ( Site 0105), Buenos Aires

C1012AAR

IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 0107), Buenos Aires

T2N 4Z6

Heritage Medical Research Clinic ( Site 0302), Calgary

00161

Policlinico Umberto I ( Site 0801), Rome

06700

Arké Estudios Clínicos S.A. de C.V.-Gastroenterology-Hepatology ( Site 0906), Mexico City

Centro de Investigación y Gastroenterología ( Site 0902), Cuauhtémoc

87-100

Nasz Lekarz Przychodnie Medyczne ( Site 1105), Torun

01-868

Centrum Medyczne Pratia Warszawa ( Site 1107), Warsaw

40-156

Clinical Medical Research ( Site 1101), Katowice

41-400

ID Clinic ( Site 1100), Mysowice

03722

Severance Hospital, Yonsei University Health System ( Site 1305), Seoul

06351

Samsung Medical Center-Gastroenterology/Internal Medicine ( Site 1302), Seoul

08308

Korea University Guro Hospital ( Site 1300), Seoul

08035

Hospital Universitari Vall d'Hebron-Liver Unit - Department of Internal Medicine ( Site 1400), Barcelona

06100

Ankara University Department of Hematology, Clinical Research Unit ( Site 1603), Ankara

06230

Hacettepe Universitesi-internal diseases ( Site 1602), Ankara

06560

Gazi Universitesi-gastroenterology ( Site 1605), Ankara

02002

Adonis Plus-Outpatient department ( Site 1701), Kyiv

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT04944992 - A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) | Biotech Hunter | Biotech Hunter